Related Experiment Videos
Transurethral prostatotomy versus transurethral prostatectomy in benign prostatic hypertrophy. A prospective
1Department of Urology, Odense University Hospital, Denmark.
British Journal of Urology
|May 1, 1988
Summary
Transurethral prostatotomy (TUT) and transurethral prostatectomy (TUR) offer comparable outcomes for benign prostatic hyperplasia. TUT demonstrated shorter operative times and less bleeding, with similar long-term functional results for non-enlarged glands.
Area of Science:
- Urology
- Surgical Innovation
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in men over 60.
- Symptomatic BPH often requires surgical intervention.
- Transurethral surgical techniques are standard treatments.
Purpose of the Study:
- To compare the efficacy and safety of transurethral prostatotomy (TUT) versus transurethral prostatectomy (TUR).
- To evaluate outcomes in patients with symptomatic BPH, including those with acute urinary retention.
Main Methods:
- A prospective randomized trial comparing TUT (24 patients) and TUR (25 patients).
- Patients were aged 60+ with symptomatic BPH.
- Outcomes assessed included operative time, bleeding, catheterization duration, hospitalization, urinary flow rate, and long-term success rates.
Main Results:
- TUT group showed shorter operative time and less post-operative bleeding.
- No significant differences in catheterization or hospitalization duration between groups.
- One-year follow-up revealed similar urinary flow rates and positive culture rates.
- TUT success rate was 82% (4 failures), TUR success rate was 78% (1 incontinence, 4 strictures).
Conclusions:
- TUT and TUR provide similar functional results for treating benign prostatic hyperplasia in non-enlarged glands.
- TUT may offer advantages in reduced operative time and bleeding.
- Both procedures have comparable long-term efficacy and complication profiles for suitable candidates.